Back
Kaival Brands Innovations Group Vs. Novartis AG Industry Stock Comparison
Sell
16
KAVL
Kaival Brands Innovations Group
Last Price:
$0.59
Seasonality Move:
668.09%
Buy
60
NVSEF
Novartis AG
Last Price:
$107.20
Seasonality Move:
5.97%
Sell
16
Kaival Brands Innovations Group (KAVL)
is a Sell
Is Kaival Brands Innovations Group a Buy, Sell or Hold?
-
The current Kaival Brands Innovations Group [KAVL] share price is $0.57. The Score for KAVL is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
KAVL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $107.55. The Score for NVSEF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KAVL Stock Price Chart
What is Kaival Brands Innovations Group's stock price today?
-
The Kaival Brands Innovations Group share price today is $0.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KAVL is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $107.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight buying pressure.
KAVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 29.68 | Sell |
Chaikin Money Flow: | -13905 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.58 - 0.8) | Sell |
Bollinger Bands (100): | (0.68 - 1.14) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.1 | Buy |
Relative Strength Index (14 RSI): | 45.62 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.22 - 114.3) | Sell |
Bollinger Bands (100): | (98.5 - 109.52) | Buy |
KAVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.57 | Sell |
20-day SMA: | 0.65 | Sell |
50-day SMA: | 0.95 | Sell |
200-day SMA: | 1.02 | Sell |
8-day EMA: | 0.59 | Sell |
20-day EMA: | 0.67 | Sell |
50-day EMA: | 0.82 | Sell |
200-day EMA: | 1.57 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.3 | Sell |
20-day SMA: | 111.39 | Sell |
50-day SMA: | 106.68 | Buy |
200-day SMA: | 106.91 | Buy |
8-day EMA: | 111.01 | Sell |
20-day EMA: | 110.56 | Sell |
50-day EMA: | 107.88 | Sell |
200-day EMA: | 104.91 | Buy |
Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kaival Brands Innovations Group Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |